Haidan Liu

2.1k total citations
53 papers, 1.6k citations indexed

About

Haidan Liu is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Haidan Liu has authored 53 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 16 papers in Oncology and 16 papers in Immunology. Recurrent topics in Haidan Liu's work include Ubiquitin and proteasome pathways (11 papers), Cancer-related Molecular Pathways (11 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). Haidan Liu is often cited by papers focused on Ubiquitin and proteasome pathways (11 papers), Cancer-related Molecular Pathways (11 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). Haidan Liu collaborates with scholars based in China, United States and South Korea. Haidan Liu's co-authors include Xinfang Yu, Ya Cao, Li Zhou, Wenbin Liu, Hui Zheng, Duosha Hu, Wěi Li, Feng Gao, Wei Li and Zigang Dong and has published in prestigious journals such as Journal of Clinical Investigation, Blood and PLoS ONE.

In The Last Decade

Haidan Liu

50 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Haidan Liu China 28 981 365 345 326 132 53 1.6k
Dennis Ma Canada 21 844 0.9× 424 1.2× 468 1.4× 322 1.0× 115 0.9× 32 1.9k
Hudie Wei China 14 835 0.9× 211 0.6× 550 1.6× 220 0.7× 155 1.2× 31 1.5k
Lijun Di China 25 1.0k 1.1× 236 0.6× 602 1.7× 389 1.2× 62 0.5× 102 1.9k
Bingtao Hao China 23 1.4k 1.4× 354 1.0× 383 1.1× 316 1.0× 38 0.3× 76 1.9k
Jing Du China 20 1.0k 1.0× 376 1.0× 313 0.9× 535 1.6× 63 0.5× 53 1.8k
Katiuscia Dallaglio Italy 21 1.0k 1.1× 300 0.8× 644 1.9× 395 1.2× 56 0.4× 31 1.8k
Yubo Tang China 20 1.0k 1.0× 145 0.4× 314 0.9× 606 1.9× 183 1.4× 49 1.6k
Jin‐Ku Lee South Korea 20 903 0.9× 268 0.7× 467 1.4× 455 1.4× 52 0.4× 34 1.7k

Countries citing papers authored by Haidan Liu

Since Specialization
Citations

This map shows the geographic impact of Haidan Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haidan Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haidan Liu more than expected).

Fields of papers citing papers by Haidan Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haidan Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haidan Liu. The network helps show where Haidan Liu may publish in the future.

Co-authorship network of co-authors of Haidan Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Haidan Liu. A scholar is included among the top collaborators of Haidan Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haidan Liu. Haidan Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Ming, Qin Zhao, Xiaocong Wang, et al.. (2023). Dioscin inhibiting EGFR-mediated Survivin expression promotes apoptosis in oral squamous cell carcinoma cells. Journal of Cancer. 14(11). 2027–2038. 5 indexed citations
2.
Gong, KeWei, et al.. (2023). Successful management of a rare case of juvenile giant right ventricular myxoma. Frontiers in Surgery. 9. 1102742–1102742.
3.
Zhou, Huiling, Li Zhou, Xuyang Hou, et al.. (2023). Skp2-mediated MLKL degradation confers cisplatin-resistant in non-small cell lung cancer cells. Communications Biology. 6(1). 805–805. 20 indexed citations
4.
Li, Ming, Feng Gao, Yu Gan, et al.. (2022). Stabilization of MCL-1 by E3 ligase TRAF4 confers radioresistance. Cell Death and Disease. 13(12). 1053–1053. 14 indexed citations
5.
Sun, Yin, et al.. (2022). Evolutionary game model of health care and social care collaborative services for the elderly population in China. BMC Geriatrics. 22(1). 616–616. 7 indexed citations
6.
Zhou, Huiling, et al.. (2022). Epithelial-mesenchymal reprogramming by KLF4-regulated Rictor expression contributes to metastasis of non-small cell lung cancer cells. International Journal of Biological Sciences. 18(13). 4869–4883. 7 indexed citations
7.
Zhou, Huiling, et al.. (2022). Case Report: Mycobacterium senegalense Infection After Cholecystectomy. Frontiers in Public Health. 10. 899846–899846. 1 indexed citations
8.
Yu, Xinfang, Wei Li, Qipan Deng, et al.. (2020). MYD88 L265P elicits mutation-specific ubiquitination to drive NF-κB activation and lymphomagenesis. Blood. 137(12). 1615–1627. 26 indexed citations
9.
Yang, Weipeng, et al.. (2020). Is Early Spatial Skills Training Effective? A Meta-Analysis. Frontiers in Psychology. 11. 1938–1938. 47 indexed citations
10.
Liu, Wenbin, Wei Li, Haidan Liu, & Xinfang Yu. (2019). Xanthohumol inhibits colorectal cancer cells via downregulation of Hexokinases II-mediated glycolysis. International Journal of Biological Sciences. 15(11). 2497–2508. 67 indexed citations
11.
Yu, Xinfang, Wei Li, Zhenkun Xia, et al.. (2017). Targeting MCL-1 sensitizes human esophageal squamous cell carcinoma cells to cisplatin-induced apoptosis. BMC Cancer. 17(1). 449–449. 41 indexed citations
12.
Park, Chanmi, Hye-Min Kim, Dong Hyun Kim, et al.. (2016). Ginsenoside Re Inhibits Osteoclast Differentiation in Mouse Bone Marrow-Derived Macrophages and Zebrafish Scale Model. Molecules and Cells. 39(12). 855–861. 21 indexed citations
13.
Duan, Zhi, Hui Zheng, Haidan Liu, et al.. (2015). AID expression increased by TNF-α is associated with class switch recombination of Igα gene in cancers. Cellular and Molecular Immunology. 13(4). 484–491. 13 indexed citations
14.
Liu, Kangdong, Chanmi Park, Hanyong Chen, et al.. (2014). Eupafolin suppresses prostate cancer by targeting phosphatidylinositol 3‐kinase‐mediated Akt signaling. Molecular Carcinogenesis. 54(9). 751–760. 30 indexed citations
15.
Liu, Haidan, Joonsung Hwang, Wei Li, et al.. (2013). A Derivative of Chrysin Suppresses Two-Stage Skin Carcinogenesis by Inhibiting Mitogen- and Stress-Activated Kinase 1. Cancer Prevention Research. 7(1). 74–85. 20 indexed citations
16.
Duan, Zhi, Hui Zheng, San Xu, et al.. (2013). Activation of the Ig Iα1 promoter by the transcription factor Ets-1 triggers Ig Iα1–Cα1 germline transcription in epithelial cancer cells. Cellular and Molecular Immunology. 11(2). 197–205. 21 indexed citations
18.
Hu, Duosha, Tong Sun, Wei Ren, et al.. (2008). The Polymorphisms on Igκ Gene Are Related to Susceptibility of Breast Cancer and Gastric Cancer. Genetic Testing. 12(4). 575–580. 8 indexed citations
19.
Zheng, Hui, Ming Li, Wei Ren, et al.. (2006). Expression and secretion of immunoglobulin alpha heavy chain with diverse VDJ recombinations by human epithelial cancer cells. Molecular Immunology. 44(9). 2221–2227. 78 indexed citations
20.
Zheng, Hui, Ming Li, Haidan Liu, et al.. (2006). Immunoglobulin alpha heavy chain derived from human epithelial cancer cells promotes the access of S phase and growth of cancer cells. Cell Biology International. 31(1). 82–87. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026